Silymarin protected the cerebral tissue from endoplasmic reticulum stress
, 2, 3, 4
Abstract
Background: Our aim is to explore silymarin’s protective effects against endoplasmic reticulum (ER) stress via protein kinase R-like endoplasmic reticulum kinase (PERK) modulation and elucidate potential enriched pathways through in silico analysis of silymarin-associated PERK protein interactors in cerebral ischaemia-reperfusion (IR) injury.
Materials and methods: 30 rats were categorized into three groups: sham, IR and IR + silymarin groups. Cerebral IR damage was not induced. Only the MCA was identified and clamped without further intervention. Sham group received only physiological serum intravenously. IR group, rats were exposed to 2 hours ischaemia and following 3 hours reperfusion. In IR + silymarin group received 1 μg/kg silymarin intravenously (i.v.) before inducing cerebral IR. Cerebral tissues were processed for histological tissue preparation. Hematoxylin-Eosin and PERK immunostaining was applied. In Cytoscape software, we imported and integrated the silymarin and PERK protein-protein interaction networks generated from the STITCH and STRING databases, respectively. Subsequently, Reactome pathway annotation was performed for this intersected network.
Results: In the sham group, neurons were large and round with oval nuclei, and no histopathological changes were observed. In the IR group, neurons and neuroglial cells showed degeneration with pyknotic nuclei, apoptotic bodies, dilated and congested cerebral capillaries, and numerous vacuoles. After silymarin treatment, the IR + silymarin group showed a restoration of normal histology, with more regular neural and neuroglial cells and decreased vessel dilation and congestion. PERK immunoexpression was mainly negative in the sham group, increased in the IR group, and decreased again in the IR + silymarin group. Upon intersecting the interactors of silymarin and PERK, 17 common proteins were identified. Reactome pathway analysis revealed potential impacts of these proteins on key pathways including immune and cytokine signaling, apoptosis, estrogen signaling, and extracellular matrix degradation.
Conclusions: Silymarin’s targeting of PERK offers a promising approach to alleviate ER stress and potentially modulate multiple critical pathways in cerebral ischaemia reperfusion, serving as a comprehensive therapeutic strategy for managing cerebral IR injury.
Keywords: cerebral ischaemia reperfusionER stressPERKreactome pathwaySilymarin
References
- Ashique S, Mohanto S, Kumar N, et al. Unlocking the possibilities of therapeutic potential of silymarin and silibinin against neurodegenerative Diseases — a mechanistic overview. Eur J Pharmacol. 2024; 981: 176906.
- Avinca Ö, Kaplan Ö, Aşır F. Effect of biochanin-A on the cerebellum in cerebral ischemia reperfusion injury. J Cukurova Anesth Surg Sci. 2024; 7(1): 47–51.
- Chung HS, Lee BS, Ma JY. Ethanol extract of Mylabris phalerata inhibits M2 polarization induced by recombinant IL-4 and IL-13 in murine macrophages. Evid Based Complement Alternat Med. 2017; 2017: 4218468.
- Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001; 94(6): 1133–1138.
- DeGracia DJ, Kumar R, Owen CR, et al. Molecular pathways of protein synthesis inhibition during brain reperfusion: implications for neuronal survival or death. J Cereb Blood Flow Metab. 2002; 22(2): 127–141.
- Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006; 17(6): 1503–1520.
- Dhir N, Jain A, Sharma AR, et al. PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling. Metab Brain Dis. 2023; 38(4): 1177–1192.
- Ermiş IS, Deveci E, Aşır F. Effects of quince gel and hesperidin mixture on experimental endometriosis. Molecules. 2023; 28(16).
- Fanoudi S, Alavi MS, Mehri S, et al. Milk thistle (Silybum Marianum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug Chem Toxicol. 2020; 43(3): 240–254.
- Gelen V, Özkanlar S, Kara A, et al. Citrate-coated silver nanoparticles loaded with agomelatine provide neuronal therapy in acute cerebral ischemia/reperfusion of rats by inhibiting the oxidative stress, endoplasmic reticulum stress, and P2X7 receptor-mediated inflammasome. Environ Toxicol. 2024; 39(3): 1531–1543.
- Gharibani P, Modi J, Menzie J, et al. Comparison between single and combined post-treatment with S-Methyl-N,N-diethylthiolcarbamate sulfoxide and taurine following transient focal cerebral ischemia in rat brain. Neuroscience. 2015; 300: 460–473.
- Guo MM, Qu SB, Lu HL, et al. Biochanin A alleviates cerebral ischemia/reperfusion injury by suppressing endoplasmic reticulum stress-induced apoptosis and p38MAPK signaling pathway and . Front Endocrinol (Lausanne). 2021; 12: 646720.
- Gupta S, Gupta YK. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats. J Ethnopharmacol. 2017; 197: 118–127.
- Hayashi T, Saito A, Okuno S, et al. Damage to the endoplasmic reticulum and activation of apoptotic machinery by oxidative stress in ischemic neurons. J Cereb Blood Flow Metab. 2005; 25(1): 41–53.
- Hou YC, Liou KT, Chern CM, et al. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation. Phytomedicine. 2010; 17(12): 963–973.
- Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003; 284(1): G15–G26.
- Kaminski KA, Bonda TA, Korecki J, et al. Oxidative stress and neutrophil activation — the two keystones of ischemia/reperfusion injury. Int J Cardiol. 2002; 86(1): 41–59.
- Karimi G, Vahabzadeh M, Lari P, et al. "Silymarin", a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci. 2011; 14(4): 308–317.
- Keşim DA, Aşır F, Ayaz H, et al. The effects of ellagic acid on experimental corrosive esophageal burn injury. Curr Issues Mol Biol. 2024; 46(2): 1579–1592.
- Khan TA, Bianchi C, Voisine P, et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg. 2004; 128(4): 602–608.
- Kokott-Vuong A, Jung J, Fehr AT, et al. Increased post-hypoxic oxidative stress and activation of the PERK branch of the UPR in TRAP1-deficient Drosophila melanogaster is abrogated by metformin. Int J Mol Sci. 2021; 22(21).
- Land W, Messmer K, Events E. The impact of ischemia/reperfusion injury on specific and non-specific, early and late chronic events after organ transplantation. Transplant Rev. 1996; 10(2): 108–127.
- Liu X, Liu J, Zhao S, et al. Interleukin-4 is essential for microglia/macrophage M2 polarization and long-term recovery after cerebral ischemia. Stroke. 2016; 47(2): 498–504.
- Liu Z, Lv Y, Zhao N, et al. Protein kinase R-like ER kinase and its role in endoplasmic reticulum stress-decided cell fate. Cell Death Dis. 2015; 6(7): e1822.
- Luo J, Cai Y, Wei D, et al. Formononetin alleviates cerebral ischemia-reperfusion injury in rats by targeting the PARP-1/PARG/Iduna signaling pathway. Brain Res. 2024; 1829: 148845.
- Ma Y, Guo H, Zhang L, et al. Estrogen replacement therapy-induced neuroprotection against brain ischemia-reperfusion injury involves the activation of astrocytes via estrogen receptor β. Sci Rep. 2016; 6: 21467.
- Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008; 147(1): 153–159.
- Paschen W, Doutheil J. Disturbances of the functioning of endoplasmic reticulum: a key mechanism underlying neuronal cell injury? J Cereb Blood Flow Metab. 1999; 19(1): 1–18.
- Rathore P, Arora I, Rastogi S, et al. Collagen nanoparticle-mediated brain silymarin delivery: an approach for treating cerebral ischemia and reperfusion-induced brain injury. Front Neurosci. 2020; 14: 538404.
- Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 2001; 61(14): 2035–2063.
- Solenski NJ, diPierro CG, Trimmer PA, et al. Ultrastructural changes of neuronal mitochondria after transient and permanent cerebral ischemia. Stroke. 2002; 33(3): 816–824.
- Tang X, Yan T, Wang S, et al. Treatment with β-sitosterol ameliorates the effects of cerebral ischemia/reperfusion injury by suppressing cholesterol overload, endoplasmic reticulum stress, and apoptosis. Neural Regen Res. 2024; 19(3): 642–649.
- Wang L, Liu Y, Zhang Xu, et al. Endoplasmic reticulum stress and the unfolded protein response in cerebral ischemia/reperfusion injury. Front Cell Neurosci. 2022; 16: 864426.
- Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 2004; 35(11 Suppl 1): 2659–2661.
- Wu F, Liu Z, Zhou L, et al. Systemic immune responses after ischemic stroke: from the center to the periphery. Front Immunol. 2022; 13: 911661.
- Yang P, Tian YM, Deng WX, et al. Sijunzi decoction may decrease apoptosis via stabilization of the extracellular matrix following cerebral ischaemia-reperfusion in rats. Exp Ther Med. 2019; 18(4): 2805–2812.
- Zhang Q, Jia M, Wang Y, et al. Cell death mechanisms in cerebral ischemia-reperfusion injury. Neurochem Res. 2022; 47(12): 3525–3542.
- Zhu H, Hu S, Li Y, et al. Interleukins and ischemic stroke. Front Immunol. 2022; 13: 828447.
- Zille M, Farr TD, Przesdzing I, et al. Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives. J Cereb Blood Flow Metab. 2012; 32(2): 213–231.
- Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci. 1994; 307(4): 284–292.
